EcoDrugPlus

Neuronal Acetylcholine Receptor Subunit Alpha-2-Like

Ensembl ID : ENSFHEG00000009994
Gene Symbol: LOC105925915
3 Cross references
195 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSFHEG00000013273
Gene Symbol: NPY2R
3 Cross references
176 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSFHEG00000015752
Gene Symbol: NPY2R
3 Cross references
183 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSFHEG00000019611
Gene Symbol: NTSR1
3 Cross references
198 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSFHEG00000013636
Gene Symbol: NTRK1
3 Cross references
200 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSFHEG00000005652
Gene Symbol: NTRK2
2 Cross references
209 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSFHEG00000008917
Gene Symbol: NTRK3
3 Cross references
183 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSFHEG00000002558
Gene Symbol: NTRK3
3 Cross references
203 Possible Orthologues:

Neutrophil Collagenase

Ensembl ID : ENSFHEG00000021770
Gene Symbol: LOC105922163
2 Cross references
173 Possible Orthologues:

Nicastrin

Ensembl ID : ENSFHEG00000000119
Gene Symbol: NCSTN
4 Cross references
204 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSFHEG00000008659
Gene Symbol: NAMPT
3 Cross references
219 Possible Orthologues:

Nischarin

Ensembl ID : ENSFHEG00000007721
Gene Symbol: NISCH
3 Cross references
210 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).